Terms: = Breast cancer AND PAX5, Q02548, 5079, ENSG00000196092, BSAP AND Diagnosis
35 results:
1. Signet ring cell-like diffuse large B-cell lymphoma involving the breast: a case report.
Zhang L; Min Q; Bi J; Yu X; Liang Y; Shao M
BMC Womens Health; 2023 Mar; 23(1):119. PubMed ID: 36949419
[TBL] [Abstract] [Full Text] [Related]
2. Constitutional BRCA1 Methylation and Risk of Incident Triple-Negative breast cancer and High-grade Serous Ovarian cancer.
Lønning PE; Nikolaienko O; Pan K; Kurian AW; Eikesdal HP; Pettinger M; Anderson GL; Prentice RL; Chlebowski RT; Knappskog S
JAMA Oncol; 2022 Nov; 8(11):1579-1587. PubMed ID: 36074460
[TBL] [Abstract] [Full Text] [Related]
3. cancer survival in women diagnosed with pregnancy-associated cancer: An overview using nationwide registry data in Sweden 1970-2018.
Johansson ALV; Fredriksson I; Mellemkjaer L; Stensheim H; Lähteenmäki P; Winther JF; Ullenhag GJ; Lundberg FE
Eur J Cancer; 2021 Sep; 155():106-115. PubMed ID: 34371441
[TBL] [Abstract] [Full Text] [Related]
4. Primary diffuse large B cell lymphoma of the lactating left breast. A case report and review of the literature.
Yagmur Y
Ann Ital Chir; 2020 Dec; 9():. PubMed ID: 33427203
[TBL] [Abstract] [Full Text] [Related]
5. Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases.
Vinogradova Y; Coupland C; Hippisley-Cox J
BMJ; 2020 Oct; 371():m3873. PubMed ID: 33115755
[TBL] [Abstract] [Full Text] [Related]
6. Direct costs of both inpatient and outpatient care for all type cancers: The evidence from Beijing, China.
Yin X; Xu Y; Man X; Liu L; Jiang Y; Zhao L; Cheng W
Cancer Med; 2019 Jun; 8(6):3250-3260. PubMed ID: 31062522
[TBL] [Abstract] [Full Text] [Related]
7. miRNAs 484 and 210 regulate Pax-5 expression and function in breast cancer cells.
Harquail J; LeBlanc N; Ouellette RJ; Robichaud GA
Carcinogenesis; 2019 Aug; 40(8):1010-1020. PubMed ID: 30605519
[TBL] [Abstract] [Full Text] [Related]
8. New challenges in integrated diagnosis by imaging and osteo-immunology in bone lesions.
Schiano C; Soricelli A; De Nigris F; Napoli C
Expert Rev Clin Immunol; 2019 Mar; 15(3):289-301. PubMed ID: 30570412
[TBL] [Abstract] [Full Text] [Related]
9. Paired box 5 is a novel marker of breast cancers that is frequently downregulated by methylation.
Li X; Huang J; Luo X; Yang D; Yin X; Peng W; Bi C; Ren G; Xiang T
Int J Biol Sci; 2018; 14(12):1686-1695. PubMed ID: 30416383
[TBL] [Abstract] [Full Text] [Related]
10. Competing mortality risks among women aged 50-79 years when diagnosed with invasive breast cancer, Queensland, 1997-2012.
Dasgupta P; Aitken JF; Pyke C; Baade PD
Breast; 2018 Oct; 41():113-119. PubMed ID: 30029053
[TBL] [Abstract] [Full Text] [Related]
11. Utility of Immunohistochemistry in Distinguishing Primary Adnexal Carcinoma From Metastatic breast Carcinoma to Skin and Squamous Cell Carcinoma.
Valencia-Guerrero A; Dresser K; Cornejo KM
Am J Dermatopathol; 2018 Jun; 40(6):389-396. PubMed ID: 29781860
[TBL] [Abstract] [Full Text] [Related]
12. Bone turnover markers in women with early stage breast cancer who developed bone metastases. A prospective study with multivariate logistic regression analysis of accuracy.
Lumachi F; Basso SM; Camozzi V; Tozzoli R; Spaziante R; Ermani M
Clin Chim Acta; 2016 Sep; 460():227-30. PubMed ID: 27404457
[TBL] [Abstract] [Full Text] [Related]
13. Primary Burkitt's lymphoma of the breast without Epstein-Barr virus infection: A case report and literature review.
Wei J; Lin C; Xu C; Xi Q; Wang C
Indian J Pathol Microbiol; 2015; 58(4):546-9. PubMed ID: 26549090
[TBL] [Abstract] [Full Text] [Related]
14. Statins and breast cancer stage and mortality in the Women's Health Initiative.
Desai P; Lehman A; Chlebowski RT; Kwan ML; Arun M; Manson JE; Lavasani S; Wasswertheil-Smoller S; Sarto GE; LeBoff M; Cauley J; Cote M; Beebe-Dimmer J; Jay A; Simon MS
Cancer Causes Control; 2015 Apr; 26(4):529-39. PubMed ID: 25736184
[TBL] [Abstract] [Full Text] [Related]
15. Modern mammography screening and breast cancer mortality: population study.
Weedon-Fekjær H; Romundstad PR; Vatten LJ
BMJ; 2014 Jun; 348():g3701. PubMed ID: 24951459
[TBL] [Abstract] [Full Text] [Related]
16. Primary thyroid T-lymphoblastic lymphoma: a case report and review of the literature.
Chen C; Yang Y; Jin L; Dong L; Zhang X; Xiang Y
Int J Clin Exp Pathol; 2014; 7(1):443-50. PubMed ID: 24427370
[TBL] [Abstract] [Full Text] [Related]
17. Multivitamin and mineral use and breast cancer mortality in older women with invasive breast cancer in the women's health initiative.
Wassertheil-Smoller S; McGinn AP; Budrys N; Chlebowski R; Ho GY; Johnson KC; Lane DS; Li W; Neuhouser ML; Saquib J; Shikany JM; Song Y; Thomson C
Breast Cancer Res Treat; 2013 Oct; 141(3):495-505. PubMed ID: 24104882
[TBL] [Abstract] [Full Text] [Related]
18. Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time.
Duffy SW; Parmar D
Breast Cancer Res; 2013 May; 15(3):R41. PubMed ID: 23680223
[TBL] [Abstract] [Full Text] [Related]
19. Influence of comorbidity on the effect of adjuvant treatment and age in patients with early-stage breast cancer.
Land LH; Dalton SO; Jensen MB; Ewertz M
Br J Cancer; 2012 Nov; 107(11):1901-7. PubMed ID: 23079577
[TBL] [Abstract] [Full Text] [Related]
20. Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial.
Anderson GL; Chlebowski RT; Aragaki AK; Kuller LH; Manson JE; Gass M; Bluhm E; Connelly S; Hubbell FA; Lane D; Martin L; Ockene J; Rohan T; Schenken R; Wactawski-Wende J
Lancet Oncol; 2012 May; 13(5):476-86. PubMed ID: 22401913
[TBL] [Abstract] [Full Text] [Related]
[Next]
